Phillip G Durham Selected Research

Therapeutics

1/2023	Loading Intracranial Drug-Eluting Reservoirs Across the Blood-Brain Barrier With Focused Ultrasound.
1/2023	Overcoming biological barriers to improve treatment of a Staphylococcus aureus wound infection.
12/2021	Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms.
10/2019	A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.
1/2018	Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Phillip G Durham Research Topics

Disease

4	Tuberculosis (Tuberculoses) 12/2022 - 01/2018
2	Neoplasms (Cancer) 01/2023 - 11/2022
1	Wounds and Injuries (Trauma) 01/2023
1	Stroke (Strokes) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Wound Infection (Wound Infections) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Adenocarcinoma 11/2022
1	Persistent Infection 12/2021
1	Granuloma 01/2018

Drug/Important Bio-Agent (IBA)

3	CPZEN-45IBA 12/2022 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 12/2021
2	AerosolsIBA 12/2022 - 01/2018
1	AminoglycosidesIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Capreomycin (Capastat)FDA Link 10/2019
1	pyrazinoic acidIBA 01/2018
1	PowdersIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2018
2	Microbubbles 01/2023 - 11/2022
1	Aftercare (After-Treatment) 11/2022
1	Immunotherapy 11/2022